SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JAGSONPAL FINANCE & LEASING LT

BSE: 530601 01 Jun 2025
Financial Services
₹ 65.06
Jagsonpal Finance & Leasing Ltd. is a company operating in the Financial Services sector, focusing on core business activities related to its industry.

JAGSONPAL FINANCE & LEASING LT - Share Price & Details

Market Cap
₹116.0
High /Low
131.0 / 5.73
Stock P/E
NA
Book Value
₹8.86
Dividend Yield
0.0
ROCE
-8.31
ROE
₹-8.31
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-141.0
Debt
0.00
CMP / FCF
-5,802
Debt to equity
₹0.0
NP Ann
-0.71
High price all time
131.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
1.82
Net CF
₹15.0
Net profit
-0.71
Price to book value
7.2
Interest Coverage
₹NA
Low price all time
0.94
Industry PE
25.3
Reserves
₹-2.08
Free Cash Flow
₹-0.87

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Satyam Silk Mills LtdNANANANA0
Shikhar Leasing and Trading Ltd.NANANANA0
JAGSONPAL FINANCE & LEASING LTNANANANA116.0
KIFS FINANCIAL SERVICES LTD.NANANANA11514.2
WALLFORT FINANCIAL SERVICES LTNANANANA1159.62

Peer Comparison Chart


About JAGSONPAL FINANCE & LEASING LT

Jagsonpal Finance & Leasing Ltd. has established itself in the Financial Services sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.


Latest News

Jagsonpal Finance & Leasing reports standalone net loss of Rs 0.76 crore in the March 2025 quarter

(27 May 2025)
Reported sales nil. Net loss of Jagsonpal Finance & Leasing reported to Rs 0.76 crore in the quarter ended March 2025. There were no net profit/loss...
Read more →

Sangam Finserv reports standalone net loss of Rs 1.71 crore in the March 2025 quarter

(27 May 2025)
Sales decline 80.64% to Rs 0.91 crore. Net loss of Sangam Finserv reported to Rs 1.71 crore in the quarter ended March 2025 as against net profit of Rs 1.28...
Read more →

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter

(11 May 2025)
Sales rise 34.65% to Rs 58.56 crore. Net profit of Jagsonpal Pharmaceuticals rose 85.35% to Rs 6.58 crore in the quarter ended March 2025 as...
Read more →

Jagsonpal Pharmaceuticals Reports Decline in Key Financial Metrics for March 2025

(07 May 2025)
Jagsonpal Pharmaceuticals has announced its financial results for the quarter ending March 2025, showing a decline in key performance indicators.
Read more →

Jagsonpal Pharmaceuticals | CMP: Rs 218 - 6 Indian stocks that fit in Peter Lynch’s idea of value investing

(17 Apr 2025)
With an operating revenue of Rs 253.6 crore on a trailing 12-month basis, Jagsonpal Pharmaceuticals has reported annual revenue de-growth of...
Read more →

Stocks to Watch, Feb 24: Britannia, BPCL, Mannapuram Fin, HCG, Jagsonpal

(01 Mar 2025)
Share market today: Britannia and BPCL have been removed from Nifty 50 and Jio Financial Services and Zomato have been added to the index.
Read more →